The non-invasive cancer diagnostics market is estimated to be worth around
Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed review of the overall landscape of the non-invasive cancer diagnostics market.
An analysis of the various partnerships pertaining to non-invasive cancer diagnostics, which have been established between 2016 and 2019.
An analysis of the investments made in companies engaged in the development of non-invasive cancer diagnostics.
An analysis of the initiatives of big pharma players.
A detailed acquisition target analysis.
Elaborate profiles of the key players engaged in this domain.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)Type of Tumor Marker
Diagnosis / Early Diagnosis
Target Cancer Indication
Key Geographical RegionsPress Release: Variation 1 (Format 2)
Rest of the World
Key companies covered in the report:
Thermo Fisher Scientific
For more information, please click on the following link:
Other recent offerings
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Roots Analysis Private Limited
+1 (415) 800 3415[email protected]